- Alexandria Real Estate maintains its full-year forecast for Adjusted Funds from Operations (AFFO) per share, projecting a range between $9.16 to $9.36, with an estimate at $9.18.
- The company expects earnings per share (EPS) to fall between 40 cents to 60 cents, a revision from the earlier estimate of $1.36 to $1.56.
- In the second quarter, AFFO per share was $2.33, slightly down from $2.36 year-on-year, but above the estimate of $2.29.
- Revenue for the second quarter was reported at $762.0 million, a decrease of 0.6% year-on-year, but it exceeded the estimate of $750.2 million.
- The company reported a loss per share of 64 cents, compared to an EPS of 25 cents in the same quarter the previous year, and below the estimated EPS of 56 cents.
- Alexandria Real Estate is considering selling non-core assets to meet capital requirements.
- Analyst recommendations for the company include 5 buy ratings, 8 hold ratings, and no sell ratings.
A look at Alexandria Real Estate Equities Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 5 | |
| Dividend | 5 | |
| Growth | 2 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Alexandria Real Estate Equities is positioned favorably for long-term growth and stability. With top scores in both Value and Dividend factors, the company demonstrates strong fundamentals and potential for returns. This suggests that investors seeking steady income and solid value may find Alexandria Real Estate Equities attractive.
Although the Growth, Resilience, and Momentum scores are slightly lower, they still indicate favorable prospects for the company’s future performance. Alexandria Real Estate Equities, specializing in office and laboratory space properties, serves a niche market catering to pharmaceutical, biotechnology, and research industries in key regions across the United States. Overall, the company’s strategic positioning and focus on high-demand sectors bode well for its long-term outlook.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
